Anand Patel to Isocitrate Dehydrogenase
This is a "connection" page, showing publications Anand Patel has written about Isocitrate Dehydrogenase.
Connection Strength
0.900
-
Clinical outcomes of IDH2-mutated advanced-phase Ph-negative myeloproliferative neoplasms treated with enasidenib. Br J Haematol. 2020 07; 190(1):e48-e51.
Score: 0.688
-
Novel Therapies in Myelodysplastic Syndrome: Where Do Venetoclax and Isocitrate Dehydrogenase Inhibitors Fit in? Cancer J. 2023 May-Jun 01; 29(3):188-194.
Score: 0.212